Robert E. Funck, Executive Vice President & CFO at ABBOTT LABORATORIES (ABT), sold 9,422 shares at $77.89 ($743K) on 2020-03-02, disclosed to the SEC on 2020-03-03.
Seasonal sale ($743k) by Executive Vice President & CFO — this insider has traded ABT in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.19 | 6,710 | $531K | 71.6% |
| 2 | $77.89 | 1,356 | $106K | 14.2% |
| 3 | $77.89 | 1,356 | $106K | 14.2% |
| Total | $78.82 avg | 9,422 | $743K | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $144K | — | Filing → |
| ABT | SELL | 2017-02-24 | $1.2M | — | Filing → |
| ABT | SELL | 2016-07-27 | $1.2M | — | Filing → |